Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
NCT: NCT02703207 · RECRUITING
Brief Summary
Cognitive dysfunction in the aging Veteran population is a growing health concern in the Veterans Health System. It is not known whether OSA coexisting with COPD will enhance the risk for cognitive dysfunction. The investigators sought to investigate whether these two highly prevalent diseases, that often co-exist as the 'Overlap Syndrome', combine to enhance cognitive impairment in the elderly Veteran population. Thus, the investigators will study whether elderly patients with Overlap syndrome have increased cognitive deficits compared with OSA or COPD alone. Additionally, treatment of OSA with positive airway pressure (PAP) has been shown to improve neurocognitive function in moderate-to-severe OSA while cognitive decline in COPD may be reversible through treatment with long-term oxygen therapy. The investigators will also study whether treatment with positive airway pressure (PAP) and supplemental oxygen vs PAP alone will improve cognitive function and improve quality of life of elderly Veterans.
Frequently Asked Questions
What is Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD?
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD is a clinical trial registered under NCT02703207. Current status: RECRUITING.
What is the status of NCT02703207?
The current status of NCT02703207 (Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD) is: RECRUITING.
When did Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD start?
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD started on 2016-08-17.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.